Abiomed, Inc.ABMDNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank79
3Y CAGR-3.5%
5Y CAGR+3.7%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-3.5%/yr
vs +6.4%/yr prior
5Y CAGR
+3.7%/yr
Recent deceleration
Acceleration
-9.9pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
202214.59-14.1%
202116.98+117.7%
20207.80-51.9%
201916.21-25.1%
201821.64+78.0%
201712.16+0.1%
201612.14-3.8%
201512.63+126.4%
20145.58+23.2%
20134.53-